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Abstract
The double-stranded RNA (dsRNA) activated protein kinase, PKR, is one of the 
several enzymes induced by interferons and a key molecule mediating the antiviral 
effects of interferons.  PKR contain an N-terminal, double-stranded RNA binding domain 
(dsRBD), which has two tandem copies of the motifs (dsRBM I and dsRBM II).  Upon 
binding to viral dsRNA, PKR is activated via autophosphorylation.  Activated PKR has 
several substrates; one of the examples is eukaryotic translation initiation factor 2 
(eIF2a).  The phosphorylation of eIF2a leads to the termination of cell growth by 
inhibiting protein synthesis in response to viral infection.  The objective of this project 
was to characterize the dsRBM I and define the dsRNA binding using biophysical 
methods. First, the dsRBM I gene was cloned from a pET-28b to a pET-11a 
expression plasmid.  N-terminal poly-histidine tags on pET-28b are for affinity 
purification; however, these tags can alter the structure and function of proteins, thus the 
gene of dsRBM I was transferred into the plasmid without tags (pET-11a) and expressed 
as a native protein.  The dsRBM I was transformed into and expressed by Rosetta 
DE3plyS expression cells.  Purification was done by FPLC using a Sepharose IEX ion 
exchange followed by Heparin affinity column; yielding pure protein was assayed by 
PAGE.
Analytical Ultracentrifugation, Sedimentation Velocity, was used to characterize 
free solution association state and hydrodynamic properties of the protein.  The slight 
decrease in S-value with concentration is due to the hydrodynamic non-ideality.  No self 
association was observed.  The obtained molecule weight was 10,079 Da.  The calculated 
sedimentation constant at zero concentration at 20°C in water was 1.23 and its friction 
coefficient was 3.575 × 10-8.  The frictional ratio of sphere and dsRBM I became 1.30.  
Therefore, dsRBM I must be non-globular and more asymmetric shape.
Isolated dsRBM I exhibits the same tertiary fold as compared to context in the full 
domain but it exhibited weaker binding affinity than full domain to a 20 bp dsRNA.  
However, when the conditions allowed for its saturation, dsRBM I to 20 bp dsRNA has 
similar stoichiometry as full dsRBD.Introduction
I.1 Double-Stranded RNA binding protein
Molecule recognition of double-stranded RNA (dsRNA) has a critical role in 
numerous cell regulatory processes, such as trafficking, editing, maturating of cellular 
RNA, interferon antiviral response, and RNA interference.  Although proteins involved in 
the molecular recognition of dsRNA have varying functions and can identify their 
specific dsRNA targets, they have structural similarities.  Large and diverse classes of 
proteins that bind to dsRNA do so by utilizing a 65-75 amino acid dsRNA binding motif 
(dsRBM) and all of the dsRNA binding protein family members possess at least one copy 
of the dsRBM with which to identify dsRNA (Fierro-Monti et al., 2000).  These proteins 
can have multiple copies of the dsRBMs, which compose a dsRNA-binding domain 
(dsRBD).  The study of protein-dsRNA binding may be helpful to find the way to control 
the functions of those dsRNA-binding proteins.  However, a fundamental understanding 
of the protein-dsRNA recognition and binding selectivity is currently being established.
There are at least nine families of functionally diverse proteins containing one or 
more dsRBMs and currently the list of homologous sequences is over 100 that are present 
in proteins from different organisms, including viruses, bacteria and lower and higher 
eukaryotes.
I.2 RNA-activated protein kinase, PKR
Interferons are cellular proteins with antiviral activity secreted by vertebrate cells 
in response to virus infection or antigen stimulation.  Healthy cells do not synthesize 
detectable amounts of interferon and formation of interferons must be induced.  
Interferons are produced by virus-infected cells to protect uninfected cells against 
infection or to decrease the chance that virus infection will be able to initiate a productive 
multiplication cycle in them.  Interferons can interact with non-infected cells and induce 
in these cells an antiviral state; therefore, replication of virus is blocked in interferon-
treated cells (Joklik et al., 1988).
The dsRNA activated protein kinase (PKR) is one of several enzymes induced by 
interferons and is one of the key molecules mediating the antiviral effects of interferons 
(Stark et al., 1998).  It plays a central role in the biological activity of interferons, which 
are widely employed in the treatment of cancer and viral infections.  The importance of 
this antiviral pathway is highlighted by the diverse mechanisms that viruses have evolved 
to combat PKR (Gale et al., 1998).  A high proportion (60 ~ 80 %) of hepatitis C patients 
fails to respond to or suffers relapses after interferon therapy.  The cause of hepatitis C 
resistance to interferon has been identified as a viral protein that directly inhibits PKR.  
Interferon therapy is also not successful against HIV because this virus uses multiple 
mechanisms to counteract PKR.  Thus, the therapeutic effectiveness of interferons is 
compromised by disease specific resistance and by side effects, including fever, mood 
disorders, and fatigue.  Interferon activates a large number of signaling pathways; 
therefore, selective activation of one therapeutically relevant component, such as PKR, 
may lead to reduced side effects and improved clinical outcomes.  Direct regulation of 
PKR activity may provide an effective way of inducing therapeutic apoptosis in infected 
or malignant cells.  A detailed understanding of the mechanism of PKR activation is 
required to effectively target this enzyme for clinical intervention against cancer and viral 
infections.  
PKR is synthesized in an inactive state, but upon binding to dsRNA it becomes 
autophosphorylated and capable of phosphorylating other proteins.  There is a new 
discovery in Cole’s lab that PKR can become autophosphorylated in the absence of 
dsRNA; the reaction is induced by self-association (Lemaire et al., 2005).  Although self-
association of unphosphorylated PKR is weak, this discovery may open new approaches 
to investigate the PKR activation process.  Phosphorylated PKR can phosphorylate 
eukaryotic initiation factor 2 (eIF2), thus blocks protein synthesis.  Therefore, 
production of dsRNA during viral infection leads to PKR activation and inhibition of 
viral protein synthesis.  The dsRBMs of PKR are similar to a molecular switch that 
regulates its kinase activity (Carlson et al., 2003).  However, several viruses have 
evolved RNAs that can bind to PKR and block activation of the kinase, in doing so they 
can avoid the cell’s endogenous antiviral response.  As a result, PKR has two classes of 
RNA ligands; kinase activating and kinase inhibiting (Conrad et al., 2001).  Despite 
extensive investigations, the features that distinguish RNAs that activate from those that 
fail to activate remain poorly understood.  Development of structure-function 
relationships of RNA activators will provide a rational basis for the design of drugs to 
specifically modulate the function of PKR.  In addition, studies of dsRNA-independent 
activation may lead to methods to circumvent inhibition of PKR by kinase inhibiting 
RNA ligands.
Human PKR is a large protein consisting of 551 amino acids.  The N-terminal 
region is the dsRNA binding domain and the C-terminal region is the kinase domain 
(Figure 1).  The RNA binding domain contains two copies of a 90 amino acid dsRBM 
labeled dsRBM I and dsRBM II.  Studies with truncated PKR proteins show that dsRBM 
I (p10a) is capable of independently binding to dsRNA (Tian et al., 2001).  The second 
motif (p10b) binds RNA much more weakly.
Figure 1 Structure of PKR (Tian et al., 2000)
I.3. Why study dsRBM I binding?
A fundamental understanding of the protein-dsRNA recognition and binding 
selectivity is currently being established and the study of protein-dsRNA binding is 
helpful to find the way to control the functions of those dsRNA-binding proteins.  The 
selective activation of signaling pathways may lead to improvement in clinical 
application against cancer and viral infections.  Direct regulation of PKR activity may 
provide an effective way of inducing therapeutic apoptosis in infected or malignant cells.  
A detailed understanding of the mechanism of PKR activation is required to effectively 
target this enzyme.  The dsRBMs play a key role in PKR function and regulation, 
although their exact role in PKR activation is not clear yet.
The study of an isolated dsRBM I is important for promoting better understanding 
of PKR-RNA binding mechanism.  In Cole’s lab, studies of the dsRBD-RNA interaction 
have been pursued earlier (Ucci et al., 2004).  The dsRBD binds to dsRNA as one object, 
thus the role of each of the two dsRBMs in binding cannot be seen.  Studies of the 
interaction of isolated dsRBM I with dsRNA would give a more detailed understanding.  
Also, the stoichiometry for binding of the dsRBD to a 20 bp dsRNA does not agree with 
published binding models, which has lead to a new overlapping lattice model of dsRBD-
RNA binding (Ucci et al., 2004).  In order to test this model, characterization of the 
simpler dsRBM I-dsRNA interaction is necessary.
I.4 Structural Studies with Affinity Cleavage
In order to clarify the differences between activating and inhibiting PKR-RNA 
complex, affinity cleavage data have been generated to define the contribution of each of 
the dsRBMs upon binding dsRNA.  Mutations are introduced to control PKR binding 
strength to dsRNA in each dsRBM by altering its amino acid side chains.  The affinity 
cleavage technique is originally developed as a tool to study DNA binding proteins.  The 
principle of the method is to elucidate specific structural elements using the cleavage 
pattern of altered point mutations.  The point mutations are designed to change the 
strength of protein-dsRNA bindings.  It is widely used to define structural features of 
complexes between proteins and nucleic acids.  In a typical experiment, a hydroxyl 
radical generator, FeEDTA, is site-specifically and covalently attached to a nucleic acid 
binding protein, then the hydroxyl radicals are generated which locally cleave the nucleic 
acid.  Finally, this cleavage pattern is mapped onto the dsRNA sequence.  The resulting 
data map is used to define structural elements that determine binding selectivity, such as 
the number of binding sites present on the nucleic acid, the location of the binding sites, 
the orientation of the protein on the nucleic acid, and cooperativity of multiple protein 
motifs.
I.5 Two binding mechanisms of dsRBMs
In Beal’s laboratory, the dsRBD was modified with cysteine residue that can 
conjugate with bromoacetyl-FeEDTA at three positions, which are D38C and E29C of 
dsRBM I and Q120C of dsRBM II (Spanggord et al., 2002).  The affinity cleavage data 
were used to create models for the complexes formed by juxtaposing the modified site of 
the protein with the cleaved nucleotides in the RNA.  The inhibiting RNA is derived from 
the Epstein Barr Virus (EBER 1) and the activating RNA is derived from HIV TAR.  
With multiple modifications on a single motif, it is possible to establish the orientation 
and approximate position.
In case of an inhibiting RNA, only dsRBM I binds to the dsRNA at two distinct 
sites but dsRBM II does not bind to the dsRNA at all.  The inhibiting RNA only interacts 
with the dsRBM I, allowing the dsRBM II to inhibit the kinase domain of PKR (Vuyisich 
et al., 2002).  It seems as if the viral RNA is designed to sequester two equivalents of 
PKR in an inactive state to support viral proliferation.
In contrast, in the case of an activating RNA, both dsRBM I and dsRBM II bind 
to the distinctive sites on the same RNA ligand simultaneously (Figure 2).  It appears that 
simultaneous binding to TAR relieves the inhibitory contacts to the kinase domain and 
supports activation of protein.  These data agree with the observations that longer duplex 
regions are required for PKR activation, although only 16-18 bp is sufficient to support 
binding of one dsRBM of PKR.
Figure 2: A. Crystal structure of the X. laevis RNA binding protein A (Xlrbpa) bound to dsRNA.  Three regions 
on the RNA contacted by dsRBM (Ryter and Schultz, 1998).  B. NMR structure of Staufen’s third dsRBM 
bound to a stem-loop RNA (Ramos et al., 2000).  C. Sequence alignment of numerous dsRBMs.  D. Model of 
HIV TAR RNA binding with PKR (Spanggord and Beal et al., 2003)
The cleavage pattern with kinase – activating RNA supports two binding sites for 
dsRBM I and one binding site for dsRBM II.  The cleavage pattern derived from dsRBM 
II overlapped with one of the dsRBM I sites, so it seems both motifs do not bind to this 
site simultaneously.  However, the second binding site for dsRBM I could be occupied 
with simultaneous binding by dsRBM II.  
In order to test the dependence of dsRBM I on dsRBM II for binding, a K150A 
mutation in dsRBM II was introduced to reduce the affinity of dsRBM II.  The K150A 
mutation has been shown to decrease the binding affinity of PKR for RNA (Patel et al., 
1996).  The mutant protein was labeled with bromoacetyl-FeEDTA at dsRBM I.  The 
two binding sites of dsRBM I are at the 5’-stem loop and 3’-stem loop.  The 5’-stem 
binds to only dsRBM I and 3’-stem may bind to either dsRBM I or dsRBM II.  The 
modified protein shows decreased cleavage at 5’-stem loop.  This indicates that the 
binding of dsRBM I to the 5’-stem loop site is dependent on dsRBM II binding 
(Spanggord et al., 2002).  Decreased affinity of dsRBM II to RNA leads also to an 
increased efficiency of cleavage at the 3’-stem by dsRBM I.  For the further investigation 
of simultaneous binding, RNA concentration was reduced so that only the 3’-stem 
binding site was occupied.  As a result, dsRBM I bound the RNA but dsRBM II did not.  
Consequently, there are two binding mechanisms observed from above data; the 
cooperative binding of both motifs in one complex, and independent binding of dsRBM I 
in a separate protein-RNA complex.  
These experiments also address the intrinsic binding selectivity.  These dsRBMs 
may not exhibit strict sequence specificity; however, they clearly have the ability to 
distinguish distinct structural features of RNA (Carlson et al., 2003).  The dsRBMs show 
the ability to bind to known RNA ligands in a site-selective manner.  Additionally, the 
differences of selectivity for binding between two motifs are observed.  The affinity 
cleavage data suggest that dsRBMs do not bind to kinase-inhibiting RNA simultaneously 
and have two distinct binding sites only for dsRBM I but not for dsRBM II.  In contrast, 
the data suggest that both dsRBM I and dsRBM II can bind to kinase-activating RNA 
simultaneously.
I-6 Sedimentation of Particles in a Gravitational Field
Sedimentation velocity is a useful tool to understand some of the physical 
characteristics of proteins.  Initially uniform protein solution is placed in the cell and very 
high angular velocity is used to cause rapid sedimentation of the protein toward the cell 
bottom.  This rapid sedimentation produces a depleted region of protein near the 
meniscus and the formation of sharp boundary between the depleted region and the 
uniformly sedimenting protein region.  The actual velocity of individual protein molecule 
cannot be measured; however, the rate of movement of the boundary can be measured.  
The sedimentation coefficient, which is directly related to the mass of the particle and 
inversely to the friction coefficient, can be found in this experiment.  When a protein 
(solute) is suspended in a buffer (solvent) and high angular velocity is applied, three 
forces act on the protein;
Friction force (F = -fu)
Buoyant force (F = -mo T2r = -T2rmvD)
Sedimenting force (F = mT2r)
There is a sedimenting force (gravitational force), F, which is proportional to the 
mass of the particle and the acceleration.  The acceleration is determined by the distance 
of the particle from the axis of rotation, r, and the square of the angular velocity, T.  
F = mT2r = (MT2r) / NA 
where m is the mass (g) of a single particle, M is the molar weight of the solute (g/mol) 
and NA is Avogadro’s number.
There is also a buoyant force (Fb), which can be explained by Archimedes’ 
principle.  And it is equal to the weight of fluid displaced:
F = - mo T2r 
where mo is the mass of fluid displaced by the particle:
mo = mv D = (MvD) / NA 
where v (mL/g) is the partial specificvolume of the protein and D (g/mL) is the density of 
the buffer.  When the density of the protein is greater than that of the buffer, the protein 
will begin to sediment.  The protein begins to move along a radial path toward the cell 
bottom.  As the protein moves toward the cell bottom, its velocity, u, will increase 
because its radial distance increases.  Because protein is moving through a viscous fluid, 
it will have a frictional force that is proportional to the velocity;
F = -fu 
where f is the friction coefficient, which depends on the shape and size of the protein.  
Asymmetric or elongated proteins have more frictional drag than globular, smooth ones.  
The equations  and  must have negative signs because these two forces act in the 
opposite direction from sedimentation force.
When the three forces come into balance:
Friction force + Buoyant force + Sedimenting force = 0 
(MT2r / NA) – (MvDT2r / NA) – fu = 0 
{MT2r (1-vD) / NA} – fu = 0 
When the terms that relate to the particle and the terms that relate to the 
experimental conditions combine:
{M(1-vD)T2r} / NAf = u / T2r = S 	
The velocity of the protein per unit gravitational acceleration (u / T2r) is called the 
sedimentation coefficient, S, and it is a physical property of the protein.  It is proportional 
to the buoyant effective molar weight of the protein and it is inversely proportional to the 
friction coefficient.  If the proteins in the buffer have different molecular weights, or 
different shapes and sizes, they move with different velocities under the application of the 
same centrifugal field, therefore, each protein will have their own unique sedimentation 
coefficients.  The unit of the sedimentation coefficient is seconds.
Measurement of the rate of sedimenting boundary broadening can be used for 
determination of the diffusion coefficient, D, which is proportional to effective size of the 
proteins:
D = RT / NAf 

where R is the gas constant and T is the absolute temperature.  The ratio of the 
sedimentation coefficient to the diffusion coefficient gives the molecular weight:
M = S°RT / D°(1-vD) 
where M is the molar weight of the solute, v is partial specific volume, and D is the 
solvent density.  The S° and D°are the values at zero concentration, which are calculated 
from several measurements at several different concentrations to remove the effects of 
interaction between proteins on their movement.  Approximate molecular weights can be 
estimated using sedimentation coefficient and diffusion coefficient.  The existence of a 
single sedimenting boundary indicates homogeneity.  On the other hand, the existence of 
multiple boundaries is evidence for multiple sedimenting species.
In cases where a protein undergoes association reactions, the molecular weight of 
the protein increases.  Therefore, the sedimentation coefficient will increase with
increasing protein concentration.  The sedimentation pattern will become complex and 
will depend on the rate of association and dissociation reactions.  If the rates of 
interconversion are slow compared to the time of the sedimentation experiment, each 
species can give rise to a separate boundary.  In this case, the molecular weights, sizes 
and shapes of the various oligomers can be analyzed.  
In order to determine a molecule weight using the sedimentation coefficient, 
accurate estimation of the diffusion coefficient is necessary.  The diffusion coefficient 
also provides information useful about the size and shape of the solute particles.  The 
frictional coefficient is proportional to the radius, R, of a spherical particle:
F = 6B0R 11
The friction coefficient increases as the shape diverge from sphere.  For 
ellipsoids, f increases with the axial ratio, and increases more for elongated ellipsoids 
than for flattened ellipsoids.  The frictional ratio is useful in estimating molecule shape.  
The frictional ratio is a comparison of the measured friction coefficient, f, with a 
calculated friction coefficient of a smooth sphere model, fo, assuming that the smooth 
sphere has the same weight and specific volume.  The frictional ratio, f / fo, has been 
found to be near 1.2 for globular proteins, and increases with asymmetry.
In sedimentation equilibrium, a small volume of an initially uniform solution is 
centrifuged at lower angular velocity.  As a protein begins to sediment towards the cell 
bottom, the concentration at the bottom increases.  The force of diffusion opposes to the 
force of sedimentation.  After an appropriate period of time, the two forces approach to 
equilibrium.  The concentration of the protein increases exponentially towards the cell 
bottom.  When it reaches to equilibrium, there is no net movement of molecules, because 
the diffusion force exactly balances sedimentation force everywhere in the cell.
C(r) = Co exp[M(1-v)T2/2rT(r2-ro2)] 12
where M is the solute molar weight (g/mol),  is the angular velocity of the rotor, c is the 
concentration of the solute (g/L) and r is the radial distance from the axis of the rotation.  
The sedimentation equilibrium is the best way for determining the molecular weight of 
macromolecule.  The radial concentration gradient is determined by the molecular weight 
of the protein.
To monitor binding of dsRBM I to dsRNA, various concentrations of protein will 
be tested.  As the concentration of protein increases, the probability of protein binding to 
dsRNA increases.  By varying the ratio of protein concentration to dsRNA concentration 
up to the saturation point, the stoichiometry of protein and dsRNA can be determined.  It 
is a measurement of the increase in the dsRNA buoyant mass in presence of saturating 
concentration of protein.  In order to achieve the stoichiometric binding conditions, the 
RNA concentration must be significantly higher than the protein-RNA dissociation 
constant.
Materials and Methods
M.1. Cloning the p10a gene in pET-11a plasmid
1-1 Preparation of plasmids
 Originally, the dsRBM I gene received from M. B. Mathews was in a pET-28b 
expression plasmid.  However, the N-terminal poly-histidine tags on pET-28b can alter 
the structure and function of proteins, thus the gene of dsRBM I was attempt to transfer 
into the pET-11a expression plasmid, which has no tags.  The p10a gene was excised 
from a pET-28 expression vector using an NdeI restriction site immediately before the 
start codon and BamHI restriction site after the stop codon.  The double digest was 
incubated at 37 °C overnight but no longer than 16 hrs.  Samples from the restriction 
digestion were desalted and concentrated to approximately 20 µL using a 
microconcentrifugal filter device, YM10.  Samples were purified on a 1.2% 
weight/volume agarose gel.  The DNA was extracted from the gel using UltraFree-DA 
kit.  DNA samples were concentrated to approximately 20 µL using the 
microconcentrifugal filter device YM10.  The insert was cloned into pET-11a to obtain 
pET-11a p10a.  The DNA was sequenced afterwards for confirmation.
a. Preparation of pET-28-p10a
A glycerol stock of pET-28, a kanamycin resistant plasmid containing the p10a 
gene, was grown in LB medium with 30 µg/mL kanamycin at 37 °C overnight to obtain a 
liquid culture.  Plasmid DNA was extracted using QIA prep spin Miniprep kit (QIAGEN 
Science) and the concentration was determined by UV spectroscopy.
b. Confirmation of p10a gene in pET-28 plasmid by ABI-prism sequencing 
b-1) DNA dilution 
Sample Stock concentration Volume taken Amount of DNA
P10a 125.6 (ng/µL) 10 µL 1256 ng
primer 5 µM (5 pmol/µL) 1 µL 5 pmol
b-2) Reaction Mixture
pure water 1 FL
template DNA 10 FL (1256ng)
T7 primer 1 FL (5 p mol)
Terminator ready reaction mix 8 FL
total 20 FL
b-3) Thermocycling Program
segment cycle Reaction temp(°C) time
1 1 melting 95 3 min
2 40 melting 95 30 sec
annealing 50 30 sec
extension 60 4 min
3 hold 4 indefinitely
end
*Mixture was heated in segment 1 for 2 min before adding Big-dye terminator ready reaction mix.
b-4) Ethanol Percipitation of PCR product
Two µL of 3M Sodium acetate (pH 5.2) and 40 µL of cold 95% ethanol (-20 ºC) 
were added to the PCR product DNA and let it sit for 30 min.  The solution was 
centrifuged at 14,000rpm for 10 min at 4 ºC.  The pellets were washed twice with 150 µL 
of cold 70% ethanol (-20 ºC) and centrifuged at 14,000 rpm for 10 min at 4 ºC.  The tubes 
were left on the bench overnight to dry.
1-2 Double restriction digestion
PpET-11a
Stock concentration Volume added (µL) Final amount
fsdH2O - 126
React 6 10 X 20 1X
DNA 194.6 ng/µL 40 7.784 µg
BSA 100X (10mg/mL) 2 100 µg/mL
Nde I 5U/µL 8 40U
BamH I 10U/µL 4 40U
Final Volume 200
-1U of enzyme was required to digest 1 µg of DNA in I hr at 37 °C, hence this represents approximately 5X over 
digestion.
PET28-p10a
Stock concentration Volume added (µL) Final amount
fsdH2O - 411
React 6 10 X 60 1X
DNA 243.7 ng/µL 90 21.933 µg
BSA 100X (10mg/mL) 6 100 µg/mL
Nde I 5U/µL 22 110U
BamH I 10U/µL 11 110U
Final Volume (µL) 600
-1U of enzyme was required to digest 1 µg of DNA in I hr at 37 °C, hence this represents approximately 5X over 
digestion.
1-3 Ligation
The following components were mixed well before adding T4 DNA ligase.  The 
entire mixture was mixed again, spun down and incubated at 16 °C overnight.
components - control background reaction 1 reaction 2
fsdH2O 8 15 0 0
5X ligase rxn buffer 4 4 4 4
PET-11 a digested 0 2 2 2
P10a insert 0 0 4 10
T4 DNA ligase 1 1 1 1
Final Volume (µL) 20 20 20 20
1-4 Transfer p10a gene
The 1.5 µL ligation mixture was transferred into 50 µL NovaBlue competent cells 
and 25 µL, 50 µL, and 100 µL of cells were plated on LB plates containing 50 µg/mL 
carbenicillin.  As a control, 1.5 µL of pET-28 was transferred into 25 µL of NovaBlue 
competent cells were plated.  The transformed plates were incubated at 37 °C overnight.  
The pET-11a-p10a expression vector was transferred into Rosetta (DE3) pLyS 
cells for protein expression (Novagen).  The transferred gene was confirmed to have no 
mutation during this procedure by ABI-Prism sequencing.  The overnight cultures of six 
colonies were made and glycerol stocks of them were stored at - 80°C.
M.2. Optimizing expression of p10a
2-1 Preparation prior to the testing induction
500 mL of LB broth was prepared in a 2 L flask by adding 12.5 g of solid LB to 
mix and was sterilized for 60 min on liquid cycle by autoclaving.  After the LB broth was 
cooled, chloramphenicol (34 µg/mL) and carbenicillin (50 µg/ml) were added.  A 5 ml 
starter culture was inoculated with pET-11a-p10a in Rossetta cells and incubated 
overnight in the shaker incubator at 37°C at a speed of 250 rpm.
2-2 Induction test
To 500 mL of LB broth in 2 L flask, 3 mL of over night culture was added.  Its 
OD (absorbance) at 600 nm, A600, was measured immediately to find its baseline.  The 
starting culture in 2 L flask was placed in shaker incubator at 37°C and the OD was 
measured in order to observe the cell growth.  When the OD value reached 0.6, 
isopropyl-	-D-thiogalactopyranoside (IPTG) was added so that the final concentration 
was 1 mM.  The pre-induced and 1, 2, 3 hour induced samples were stored for later gel 
analysis to characterize p10a induction.  
2-3 Gel analysis of induction
a. Preparation prior to the experiment
Samples (120 µL) were thawed and transferred into microtubes.  The samples 
were centrifuged at max speed for 15 min and pellets were resuspended with 120 µL of 
pure water.  Then Trichloroacetic acid (TCA) was added, so that the final concentration 
of TCA would be 10% (30 µL of 50% TCA solution).  The solution was centrifuged for 
20 min at max speed.  In order to remove TCA, 1 mL of acetone was added without 
disturbing the pellet then centrifuged for 5 min at max speed.  The pellet was dried by 
removing excess acetone and exposed to air.  The pellets were suspended with 35 µL 
pure water and SDS loading buffer was added so that the final concentration was 25% 
(12 µL).  BME was added, so that the final concentration of BME is 15% (10 µL of 
14.2M BME).  The solution was vortexed for 30 sec.  The solution was heated for 10 min 
at 70 °C.
b. Running SDS gel
The samples were loaded onto 12% Polyacrylamide precast gels and 
electrophoresed at 200 V for 40 min.  After running, the gel was stained with 500 mL 
Coomassie Brilliant Blue and heated for 30 sec at high power in a microwave oven.  
After 15 min of staining, the gel was destained for 15 min.  Then the destain solution was 
discarded and water was added, the gel was heated for 30 sec with high power and placed 
on the shaker at room temperature for 15 min.  After 15 min, water was discarded and 
fresh water was added to the gel, heated for 30 sec with high power and set for 15 min 
and it was repeated twice.
M.3 Protein purification
3-1 Cell Lysis
For p10a protein purification, cells were resuspended in buffer A (20 mM Bicine, 
50 mM NaCl, 1 mM EDTA, 5% Glycerol, 10 mM 	-mercaptoethanol, pH 8.0) 
supplemented with protease inhibitor cocktail (Sigma).  Cells were lysed by sonication 
for 20 cycles of 30 sec. on ice followed by PEI precipitation by adding 4% PEI solution 
to the suspended cell lysate to yield a 0.2% w/v final concentration.  The lysate was 
centrifuged for 15 min at 20,000 g.
3-2 Column chromatography
The supernatant was applied to an S-Sepharose ion exchange column (Amersham) 
equilibrated in buffer A and p10a was eluted using a NaCl gradient from 50 mM to 1 M.  
The peak fractions were diluted two-fold with buffer A0 (20 mM Bicine, 1 mM EDTA, 
5% Glycerol, 10 mM 	-mercaptoethanol, pH 8) in order to reduce its salt concentration 
and applied to a Heparin Sepharose column (Amersham) equilibrated in buffer A.  The 
p10a protein was eluted using the same NaCl gradient, concentrated to approximately 
8.52 mg/mL and stored at – 80 °C.
M.4. Characterizing the binding of p10a
4-1 Sedimentation velocity and sedimentation equilibrium
Analytical ultracentrifugation was performed with a Beckman-Coulter XL/I 
instrument at 20 °C.  Samples were equilibrated into analysis buffer (75 mM NaCl, 20 
mM Hepes, 0.1 mM EDTA, pH 7.5) using spin columns.  The buffer density was 
measured to be 1.0059 g/mL using an Anton Paar DMA-60 density meter.  Protein 
concentrations were assayed using A280 nm.  The following properties were calculated 
using Sednterp; 
280 in water = 2.980 x 10-3 M-1cm-1, M = 10,252.73, v-bar = 0.7399 
g/mL.  Standard 2-channel and external-loading, 6-channel centerpieces were used for 
sedimentation velocity and equilibrium experiments, respectively.  Sedimentation 
equilibrium data were fit using non-linear least- squares fitting algorithms with macros 
developed in IGOP Pro (Wavemetrics).
4-2 Circular Dichroism Spectroscopy
CD spectra was recorded on a Jasco J-715 spectrometer at 20 °C from 350 to 200 
nm with 1 nm spectral bandwidth and 50 nm/min scan rate.  CD titration of the 20 base 
pair dsRNA with p10a was performed at high RNA concentrations of 7 µM, 10 µM and 
20 µM.  The dsRNA was made by annealing top and bottom strands and its concentration 
was measured by spectroscopy.  The sample was loaded into a 2 mm path length quartz 
cuvette.  Ten scans at 262 nm were averaged for each spectrum.  Data were acquired for 
the dsRNA alone and following sequential additions from a 126 µM stock of p10a 
spectra were corrected for dilution effects, and the intensity data was plotted using 
KaleidaGraph.
20mer dsRNA
Bottom strand 20 5’-CGAAGGGCAUGAAGUUCUCC-3’
   Top strand 20 3’-GCUUCCCGUACUUCAAGAGG-5’
BS20
Mw = 6405.9 Daltons
Extinction @ 260 nm = 2.26X105 M-1cm-1 (by Excel calculator)
TS20
Mw = 6342.8 Daltons
Extinction @ 260nm = 2.16X105 M-1cm-1 
TS20-BS20 duplex
Mw = 12748.7 Daltons
Extinction @ 260 nm = 3.26X105 M-1cm-1 (.739 x T20+B20)
Extinction @ 295 nm = 2.96X104 M-1cm-1 (experimental)
V-bar = .51
(calculated from experimental buoyant weight and known SB4 density)
4-3 Nuclear Magnetic Resonance, NMR
The overall fold of the p10a protein was assayed by NMR spectra.  Protein 
enriched in 15N was prepared by growing cells minimal media.  The MOPS medium was 
prepared as the established protocol in Alexandrescu lab and enough 15N p10a protein 
was produced for NMR analysis.  The procedure was performed by Dr. Alexandrescu in 
his laboratory
Recipe of MOPS medium for 300 mL total
260 mL of sterile H2*
70 mL of 5XM buffer
0.7 mL of O solution
0.7 mL of P solution
0.4 mL of S solution
0.4 mL of 0.1% B1 stock
3.5 mL of 40% glucose
20 mM 15N Ammonium Chloride 
(*Add 15N just before induction)
M.5. Characterizing the binding of T16E p10a
5-1 Mutagenesis
a. Primer design and preparation
Introduction of a point mutation at T16E (ACA GAA), which will change one amino 
acid at position 16 in dsRBM I. 
T16E p10a coding (above) and non-coding (below) primer design
5'- GCAGGTTTGTCATGGAGGAACTTAATGAATACCGTCAGAAGCAGGG -3'
3'- CGTCCAAACAGTACCTCCTTGAATTACTTATGGCAGTCTTCGTCCC -5'
The concentration of the primers was measured with spectroscopy.
[T16E top] = 630 ng/µL
[T16E bottom] = 823 ng/µL
b. Temperature cycling and Site directed mutagenesis
Site directed mutagenesis was performed using the Quick Change Kit (Stratagene).  
The plasmid was denatured and annealed with the oligonucleotide primers containing a 
point mutation at T16E.  Using the nonstrand-displacing action of PfuTurbo DNA 
polynucrease, the mutagenic primers were extended and incorporated, resulting in nicked 
circular strands
Reaction mix; The followings were added to the small dome cap micro tube in order;
<Reaction 1> <Reaction 2>
1) pure water - 40.7µL - 35.2 µL
2) 10X reaction buffer - 5 µL - 5 µL
3) DMSO (4% of total volume) - 5 µL - 5 µL
4) plasmid pET11a-p10a - 1.5µL = 127.5 ng - 1 µL
5) T16E top primer - 1 µL = 630 ng - 125 ng
6) T16E bottom primer - 0.8 µL = 658 ng - 131.6 ng
7) dNTPs - 1 µ - 1 µL
Total - 49µL - 49 µL
Thermocycling Program
segment cycle Reaction temp(°C) time
1 1 melting 95 3 min
2 18 melting 95 30 sec
annealing 55 1 min
extension 68 14 min
3 hold 4 indefinitely
end
*Mixture was heated in segment 1 for 2 min before adding Pfu turbo enzyme
c. Digestion
The completed SDM reaction solution was digested by DpnI restriction enzyme in 
order to eliminate methylated and wild-type parent DNA template.
d. Ligation
The digested components were mixed well before adding ligase.  The entire 
mixture was mixed again, spun down and incubated at 16 °C overnight.
e. Transfer p10a gene
The ligation product was transformed into 50 µL XL1-Blue supercompent cells.  
The transformation reactions were swirled gently to mix and incubate the reactions on ice 
for 30 min.  A heat pulse was applied to the transformation reactions for 45 sec. at 42 °C 
by dipping the tube in 42 °C water bath, and then the reaction was placed on ice for 2 
min.  Appropriate volumes of cells were plated on the LB plates containing carbenicillin 
(50 µg/mL).  The transformed plates were incubated at 37 °C overnight.
The procedure described in “1-1 Preparation of plasmids” was used to make glycerol 
stocks in NovaBlue cells and Rosetta (DE3) plysS cells.  The glycerol stocks were stored 
at – 80 °C.
Results
1.Cloning the p10a gene into the pET-11a plasmid 
The NovaBlue competent cells, that contain the anpicillin resistant pET-11a 
plasmid with a p10a gene insertion, produced many colonies on the LB plates containing 
50 µg/mL carbenicillin.  In contrast, no colonies were observed for the negative control, 
the NovaBlue competent cells with kanamycin resistant plasmid pET-28, and with 
background plates lacking the insert.  This result indicated the success of p10a gene 
transfer from the pET-28 plasmid to the pET-11a plasmid.  The sequence of the pET-11a 
plasmid with p10a gene insertion was confirmed by ABI-Prism sequencing.  The glycerol 
stocks of pET-11a p10a in NovaBlue and Rosetta cells were stored for later experiments.
2. Optimizing expression of p10a by induction
The cells were grown in LB medium at 37 °C until A600 nm approximately 0.6 and 
optimal protein expression was determined to be three-hour induction with 1 mM IPTG 
at 37 °C.
Cell Growth at Induction
Time (hr) 0 1.5 2.5 3.5 4 5
A600 nm 0.055 0.021 0.03 0.092 0.247 0.6
It took about four hours to reach 0.3 OD.  After reaching to the doubling rate, the cell 
growth was exponential.  Within one hour it reached to the ideal concentration for 
induction.
MES SDS Gel Analysis of Testing Induction (figure 3)
Lane #    1  2  3   4   5    6    7    8    9   10   11  12       
  m  b    3    2    1    0    m   b    hour of induction
             17 kDa
             11 kDa       10 kDa
               6 kDa dsRBM I (p10a)
               3 kDa
Lane    1 empty
2 empty
3 empty
4 MultiMark 5 uL
5 Bench marker 5 uL
6 3-hour induction 30 uL
7 2-hour induction 30 uL
8 1-hour induction 30 uL
9 pre-induction 30 uL
10 MultiMark 5 uL
11 Bench marker 5 uL
12 empty
The gel result showed that three-hour induction had the most p10a production compared 
to 2hr, 1 hr and pre-induction.  
From 500 mL of LB in a 2 L flask, 9.49 mg/Liter of cell paste was protein was harvested.
3 Column Chromatography (figure 4)

The lysed cells were treated by PEI precipitation and centrifugation.  The 
supernatant was applied to an S-Sepharose ion exchange column (Amersham) 
equilibrated in buffer A and p10a was eluted using a NaCl gradient from 50 mM to 1 M.  
The peak fractions were diluted two-fold with buffer A0 (20 mM Bicine, 1 mM EDTA, 
5% Glycerol, 10 mM 	-mercaptoethanol, pH 8) in order to reduce its salt concentration 
and applied to a Heparin Sepharose column (Amersham) equilibrated in buffer A.  The 
p10a protein was eluted using the same NaCl gradient, concentrated to approximately 
8.52 mg/mL and stored at – 80 °C.
S Sepharose ion exchange column Heparin Sepharose affinity column
fraction #46 - #36, #41,#47 and #57 fraction #24 - #34 were analyzed by 
were analyzed by the SDS gel the SDS gel
SDS Gel Analysis of S-Sepharose Protein Purification (Figure 5)
These gels were dried instead of being scanned.  The lane 9-5 of upper gel, and lane 3 
and 4 of bottom gel are demonstrating fairly well purified p10a protein.
1. empty
2. marker
3. fraction #14
4. fraction #16
5. fraction #18
6. fraction #20
7. fraction #22
8. fraction #24
9. fraction #26
10. flow through
11. PEI precipitate
12. PEI supernatant
13. marker
14. empty
15. empty
1. empty
2. marker
3. fraction #28
4. fraction #30
5. fraction #32
6. fraction #34
7. fraction #36
8. fraction #41
9. fraction #47
10. fraction #57
11. flow through
12. PEI supernatant
13. marker
14. empty
15. empty
Lane#    13 12 11 10  9  8  7  6  5  4  3   2         
Lane#          2    3   4   5   6  7    8   9  10 11 12 13
P10a 
P10a 
SDS Gel Analysis of Heparin Sepharose Column Protein Purification (Figure 6)
Lane#        1      2      3     4      5      6      7      8      9     10    11     12      13     14     15    
Lane 1 marker, 5uL
2 fraction # 24, 20 µL
3 fraction # 25, 20 µL
4 fraction # 26, 20 µL
5 fraction # 27, 20 µL
6 fraction # 28, 20 µL
7 fraction # 29, 20 µL
8 fraction # 30, 20 µL
9 fraction # 31, 20 µL
10 fraction # 32, 20 µL
11 fraction # 33, 20 µL
12 fraction # 34, 20 µL
13 flow through 20 µL
14 starting material 20 µL
15 fraction # 15 (contaminant), 20 µL
The heparin Sepharose column was able to complete the purification process of p10a to 
produce pure p10a.  
p10a
4. Characterizing the oligomeric state of p10a (Figure 7)
4-1 Sedimentation Velocity
1. An initially uniform solution of p10a with buffer was placed in the cell and high angular 
velocity was used (55,000K) to cause rapid sedimentation of p10a toward the cell bottom.  The 
boundary between depleted p10a concentration region near the meniscus and its sedimenting 
region was analyzed.  The only one sharp sedimenting boundary indicates uniform concentration 
of solution and it suggests the homogeneity of solution, therefore, p10a is a monomer.  2. The 
single large feature at 1.2S of the C(S) graph indicates a monomeric p10a.  And a small feature at 
3.5S can be interpreted in three possible ways.  1) The p10a exists mostly monomeric state, and a 
small portion of dimer and the interconversion between monomer and dimer is slow (two peaks 
are separated), 2) A small amount of aggregation was observed, or 3) It is also possible that it is 
just an artifact.
Single large 
feature  indicates 
a monomeric 
P10a
Small feature can be 
just an artifact2. C(S)
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The sedimentation coefficient decreased slightly as protein concentration increased.  The 
slight decrease in S with concentration is due to the hydrodynamic non-ideality.  There is 
no self-association.  The calculated sedimentation constant at zero concentration at 20 °C 
in water was 1.23 and its friction coefficient was 3.575 H 10-8.  Therefore, the frictional 
ratio is 1.30.  The dsRBM I must be non-globular and have more asymmetric shape.
S°20,W = S°(1-v20,W)20,B / (1- v20,B)20,W,, S° = (1.23){(1 - .7409 H.9982)(1.01H10-2) / (1-.7409H1.00359)(1.002H10-2)} = 1.23
Ro  = (3Mv / 4NA)1/3 , Ro  = {(3H10165.65H.7409) / (4H6.022X1023)}1/3 = 1.44H10-7 
f ° = 620,BR°, f° = 6(1.01H10-2)(1.44H10-7) = 2.14H10-8 
fP = M(1- v20,B) / NA S°(1H10-13), fP = {10165.65H(1-.7049H.9982)} / (6.022H1023)H1.23(1H10-13) = 3.575H10-8 
fP / f ° = (3.575H10-8) / (2.741H10-8) = 1.30
Figure 8
S°=1.23
4-2 RNA Binding Stoichiometry (Figure 9)
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This graph shows two titration of a 20 base pair dsRNA with the dsRBM I (p10a).  
It was monitored by sedimentation equilibrium at 260 nm and 30,000 rpm.  Under these 
conditions, the absorption contribution from the protein is negligible relative to the RNA 
because the extinction coefficient of RNA (
RNA, 260nm) is 50 times more then the 
extinction coefficient of p10a protein (
protein, 260 nm).  Therefore, as the number of protein 
that bound to dsRNA increases, the buoyant mass of the RNA also increases.  The signal-
average buoyant mass of the RNA in the absence of protein was 5385 in the 2nd
experiment and 6930 in the 3rd experiment (theoretically 5944).  The calculated buoyant 
mass of p10a is 2590 in analysis buffer.  Over a protein concentration range of 0 to7 µM 
(#2) and 0 to 70 µM, M260 increased to approximately 9454.  However, it did not reach to 
saturation.  Therefore, it was not possible to determine its stoichiometry.  It is probability 
due to a weak binding of p10a. 
Exp#2 [RNA] = 1 µM
Exp#3 [RNA] = 6 µM
4-3 Nuclear Magnetic Resonance (NMR) (figure 10)
The overall folding of the p10a protein was assayed by NMR spectra.  Protein enriched in 
15N was prepared growing cells in minimal medium containing 15N-NH4Cl as the labeled 
nitrogen source.  The medium was prepared using and established protocol in 
Alexandrescu lab and enough 15N p10a protein was produced for NMR analysis.  In the 
spectrum (figure 13), the blue peaks are from dsRBD (p20) and yellow peaks are from 
dsRBM I (p10a).  Since the yellow signals are at approximately the same position as blue 
signals (protein size and/or pH differences causes slight shifts) the overall folding of 
dsRBM I in p10a and p20 are the same.
15N
1H
4-4 Circular Dichroism Spectroscopy (Figure 11)
CD spectroscopy was also performed in order to determine the binding 
stoichiometry.  In crystal structure of a related dsRBM, binding of the protein to dsRNA 
caused slight the unwinding the double helix (Ryter et al., 1998) and the ellipticity near 
260 nm is linearly related to the helical winding angle (Bloomfield et al., 2000).  Figure 
10 shows a CD titration of the 20 base pair dsRNA with dsRBM I (p10a).  It was 
performed at high RNA concentration (20 µM).  Because these data show no saturation, 
the stoichiometry of p10a - 20mer dsRNA could not be determined.
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5. Characterizing the binding of T16E p10a to a dsRNA
5-1 Mutagenesis - T16Ep10a
Through a search of the published sequence alignment of numerous dsRBMs of 
dsRNA binding proteins, the conserved sequences among the dsRBMs were found.  A 
hypothesis was suggested that a mutation from threonine (polar) to glutamate (negatively 
charged) at position 16, which is consensus among many dsRBM include RNase III, 
would strengthen the bindings of p10a to dsRNA.  Therefore, the introduction of a point 
mutation at T16E (ACA to GAA) was prepared.
The introduction of a point mutation was completed successfully.  The 
transformation and digestion of the DNA went well.  The numbers of colony on the plate 
were the following;
Reaction 1 Reaction 2
50 µL 6 6
150 µL 20 44+ DpnI
250 µL 10 45
- DpnI 150 µL     TNTC     TNTC
In order to confirm its sequence, ABI-Prism sequencing was performed and confirmed 
5-2 Sedimentation equilibrium
The following two RNA binding stoichiometry graphs (Figure 12 and 13) show 
the result of several sedimentation equilibrium experiments of p10a-dsRNA binding 
under different conditions.  In order to find its stoichiometry, several experiments were 
performed as trial and error to observe the saturation of their binding.  The RNA binding 
stoichiometry I (Figure 12) is a graph of the binding comparison between mutant p10a 
T16E and wild type p10a to 1 µM and 20bp of dsRNA at 75 mM NaCl salt concentration.  
Because p10a did not bind to dsRNA tightly, the saturation point was not observed.  
Therefore, salt concentration was lowered so that salts will not interact with the binding 
site of protein and RNA, hoping to create a better protein-RNA binding environment.  
The RNA binding stoichiometry II (Figure 12) shows the binding of p10a T16E to 1 µM 
and 20bp of dsRNA under the low salt concentration (10 mM NaCl).  In order to observe 
the saturation, the second experiment was extended to the higher ratio of p10a T16E over 
RNA.
A mutation of threonine to glutamate was introduced at position 16 and the 
mutated p10a was set to bind to 20bp dsRNA under the low salt concentration.  By 
combining the two changes (point mutation and salt concentration), the isolated p10a 
binding to dsRNA was observed up to saturation.  This result supports the previously 
generated data three to one stoichiometry of dsRBD-dsRNA (Ucci, 2004).  The modified 
salt condition is not the same as physiological condition; however, it is worth finding the 
binding stoichiometry and other character of binding mechanisms of PKR’s motif.
RNA Binding Stoichiometry I (figure 12)
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Sedimentation equilibrium was performed several times after the introduction of T16E 
mutation.  If the mutation of one amino acid was significant enough to make protein’s 
binding to dsRNA tighter, the graph should reach to saturation under such high dsRNA 
concentration.  Figure 11 shows two titration of the 20bp dsRNA by wild type of dsRBM 
I (p10a WT, blue) and mutated dsRBM I (p10a T16E, red).  In the comparison of these 
two motifs, M260 curves were similar and indicating the increase of binding of p10a to 
dsRNA.  However, the buoyant molecule weight did not reach to the point of saturation.  
The mutationT16E alone did not help to bring their binding to saturation.  Thus, the 
stoichiometry could not be determined
RNA Binding Stoichiometry II (Figure 13)
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The sedimentation equilibrium data above shows saturation with three T16E p10a 
proteins bound to 20mer dsRNA under the low salt condition (10 mM NaCl).  The 
mutation of T16E alone was not enough to make tighter binding of p10a to reach protein-
dsRNA binding saturation.  However, by lowering salt concentration to enhance binding 
of p10a to dsRNA, saturation was observed.  In the first experiment, the p10a 
concentration was not high enough and saturation was not observed.  Thus, for the second 
experiment, p10a the final concentration was increased from 8 µM to 17 µM and we were 
able to see a saturation point.  This result of three to four dsRBM I binding to 20bp 
dsRNA agrees with Cole lab’s stoichiometry result of dsRBD 20bp dsRNA (Ucci et al., 
2004).
Blue = 1st lo  NaCl data
Red = nd low aCl ta
Discussion
The dsRBMs play a key role in PKR function and regulation.  Despite extensive 
investigation, their exact role in PKR activation is still not well understood.  A detailed 
understanding of the mechanism of PKR activation is necessary to effectively target this 
enzyme for clinical intervention against cancer and viral infections.  PKR is one of the 
most studied dsRNA binding proteins and I studied dsRBM I, one of the dsRBMs at the 
N terminus of PKR using biophysical approaches.  A method of p10a expression in its 
native form was established as well as its purification method.  My study of its binding 
characterization has produced fascinating results, which may overturn established theory.  
Further investigation on the subject will be necessary to confirm the findings.
1. p10a expression
A plasmid containing the dsRBM I gene (p10a) was received from Michael B. 
Mathews (New Jersey Medical School).  The gene was in the pET-28 vector, containing 
an N-terminal polyhistidine tags, therefore, the gene needed to be transferred to pET-11a, 
non-histidine tag plasmid.  These “tags” are fused to facilitate detection and purification 
of the target protein.  However, the positively charged histidine tags may alter the 
structure and function of proteins.  Thus, the native protein without tags was required in 
my research.  The established protocol for purification of this protein was 
straightforward, only two columns were used and enough pure protein was harvested 
after the purification.  Therefore, histidine tags are unnecessary.
The cloning and expressing of recombinant proteins in E. coli were performed 
using pET vectors (Novagen).  Target genes were cloned in pET plasmids under control 
of strong bacteriophage T7 transcription, and expression was induced by providing a 
source of T7 RNA polymerase in the host cell.  When the plasmid is transferred into an 
expression host containing a chromosomal copy of the T7 RNA polymerase gene under 
lacUV5 control, the target protein was expressed upon the addition of IPTG to the 
bacterial culture.  The design of pET vectors worked favorably with p10a gene, and high 
yield protein was harvested with a three-hour induction.
Transferring of p10a gene from pET-28 to pET-11a was attempted by two 
methods.  One of the methods was double digestion of plasmids.  Both plasmids, pET-28 
with p10a gene and pET-11a, were first digested by the restriction enzymes, NdeI and 
BamHI.  After digestion, the complementary ends of the digested DNA fragments were 
annealed, and sealed by treatment with DNA ligase.  Because the selectable marker 
included on the vector was anmicillin resistance, only pET-11a containing the p10a gene 
was selected.  Synthesis of the dsRBM I expression plasmid by site directed mutagenesis 
was performed as alternative method.  A stop codon was inserted in the linker region 
between p10a (dsRBM I) and p10b (dsRBM II) using pET-11a-p20 made in Cole lab.  
Mutagenic primers were designed and the desired DNA was synthesized using the Quik-
Change kit (Stratagene).  In order to eliminate the methylated and non-mutated parent a 
DNA template, the PCR product was digested by DpnI.  Since stop codon stops 
translation, only the p10a protein should be expressed.
Theoretically, both methods are feasible and wild type p10a protein was expected
to be harvested.  However, this stage was very time consuming and challenging.  One of 
the factors contributed to this difficulty could be the size of the protein.  The p10a is a 
very small protein, it consists of only 91 amino acids, and therefore to recover this DNA 
from the gel was technically very difficult.  After many trials, the double digestion and 
cloning method produced the p10a gene in a pET-11a vector.  The product was 
transferred into XL1-Blue Supercompetent Cells.
Induction was tested by visualizing p10a expression with SDS-PAGE of whole 
cell lysate.  A study of the time-course indicated that a three-hour induction yielded the 
maximum p10a protein (figure 3).  Thus, three-hour induction was performed on a large 
scale in order to synthesize large quantity of p10a protein.
2. The p10a purification
The p10a protein purification method was adapted from a published p20 
purification method (Ucci and Cole, 2004) with slight modifications.  The buffer pH was 
decreased from pH 8.65 to pH 8.00, and the final sephacyl S-100 gel filtration was 
eliminated.  At first, cell lysis was performed on cells suspended in buffer by sonication 
and PEI precipitation was performed in order to remove nucleic acid   Protein in the 
supernatant was purified through a S-Sepharose ion exchange column followed by a 
Heparin Sepharose affinity column.  The fractions monitored during S-Sepharose column 
purification showed a single large UV peak, indicating p10a protein elution, and a few 
UV peaks of contaminant (figure 4).  The fractions of the p10a elution were visualized by 
the gel analysis and confirmed to be fairly purified protein with only few contaminants 
(figure 5).  The p10a was diluted two-fold with buffer in order to reduce salt 
concentration and was further purified through a Heparin Sepharose column equilibrated 
in buffer A.  The p10a protein eluted at 250 mM NaCl without any contaminant (figure 
6); therefore, this process resulted in p10a protein purification.  The establishment of this 
purification method was straightforward and fewer steps were required.  NMR was 
utilized to confirm folding of the isolated dsRBM I.  Since protein folding is very 
important for protein’s function, the confirmation of protein folding was important.  The 
NMR indicated that the overall folding of both dsRBD (p20) and dsRBM I (p10a) were 
the same by overlapping signals of both proteins.
3. The P10a binding to dsRNA characteristics
Analytical ultracentrifugation is a useful tool for the detailed characterization of 
protein and for understanding the stoichiometry of protein-RNA interaction in free 
solution.  Since PKR-RNA binding may have non-specific interactions, which generally 
have lower affinity and higher dissociation rates than specific interactions, it is 
particularly susceptible to artifacts associated with dissociation during the measurement.  
Solution equilibria may be defined by the gel shift and filter-binding assays under 
carefully controlled conditions; however, to achieve correct solution equilibria is 
meticulous process due to low affinity and high dissociation rates.  Analytical 
ultracentrifugation provides more accurate characterization of dsRBM I-RNA interaction.  
The Cole lab has adapted a model for non-specific protein-RNA interaction for global 
fitting of multiwavelength sedimentation equilibrium analysis (Ucci and Cole, 2004).  
For the study of the mechanism of activation PKR by RNA binding, it is important to 
understand the interaction thermodynamics of various PKR domains with a structurally 
defined dsRNA sequence.  The multiwavelength sedimentation equilibrium is a practical 
method to characterize the stoichiometry and affinity of protein –nucleic acid 
interactions.  The sedimentation equilibrium study does not require labeling of the 
reagents and uses fairly small amounts of material and measures the sequential binding of 
each protein ligand to the lattice.  Thus, the relationship between sequential binding 
constants can be determined. 
The sedimentation velocity was the first analysis performed in characterization of 
p10a protein.  In sedimentation velocity experiment, a buffer diluted p10a sample, which 
was initially uniformly distributed, was placed in the cell and high angular velocity was 
used to cause relatively rapid sedimentation of p10a towards the cell bottom.  As p10a 
was sedimenting towards the cell bottom, an evidence of homogeneity was observed by a 
single boundary.  This result suggested that p10a protein existed as monomer in a free 
solution.  In addition, C (S) analysis showed a single large feature at 1.2S, which 
indicated monomeric p10a.  There was a very small feature at 3.0S, which may be 
explained by the presence of a small amount of dimeric p10a with a very slow 
interconversion rate.  However, it was probably not the case because the sedimentation
coefficient of 3.0S is too high to a dimer relative to the monomer peak at 1.2S.  The 
dimer peak should appear about 1.5 times of the monomer peak.  It may also be explained 
by the presence of very small amount of aggregate, or it can be just an artifact.
Numerous studies have demonstrated dimerization of isolated binding motifs.  Published 
data suggest that both dsRBMs have an intrinsic ability to dimerize (dsRBM II) or 
multimerize (dsRBM I) (Tian and Mathews, 2000).  In contrast, my data indicated a 
monomeric state of dsRBM I in free solution and it contradicts the published data.  
Further investigation is required to confirm my observation.  The calculated 
sedimentation coefficient at zero concentration at 20°C in water was; S°20,W = 1.23.  The 
frictional coefficient of a smooth sphere model with the same molecular weight and 
specific volume of p10a is; f° = 2.741 x 10-8.  And measured friction coefficient of p10a 
was; fp10a = 3.575 H 10-8.  Therefore, fractional ratio fp10a / f° was 1.30, indicating non-
globular and asymmetric shape of p10a. 
Sedimentation Equilibrium was also performed in order to characterize dsRBM I-
dsRNA interaction.  This experiment was a measurement of the increase in the buoyant 
mass of dsRNA up to saturation.  If dsRBM I (p10a protein)-dsRNA interaction had 
reaches saturation, its stoichiometry could have been determined.  However, to set 
conditions so that the interaction would reach saturation was difficult due to a very weak 
affinity of isolated p10a protein.  A set of sedimentation equilibrium experiments was 
performed at dsRNA and p10a concentration.  Regardless of my effort, wild type p10a 
did not bind tight enough to reach saturation.  Therefore, mutations were introduced to 
control the protein-dsRNA binding strength by altering its amino acid side chain, T16E.  
This mutation was designed by locating conserved amino acids among tight binding 
dsRBMs.  However, this mutation did not show any change in their affinity.  An 
additional modification, lowering salt condition, was applied.  Finally, protein-dsRNA 
binding reached saturation by introducing both modifications, thus its stoichiometry was 
determined as three or four to one (figure 12).  This stoichiometry is the same as p20 and 
suggests that only dsRBM I binds to dsRNA. Therefore, a new overlapping lattice model 
of dsRBD-RNA binding, which Cole lab had introduced, was supported by my data as 
well.
Circular dichroism spectroscopy was also attempted to generate supporting data.  
To balance the protein and dsRNA concentration in order to obtain saturation was again a 
problem in this experiment.  Despite several experiments by varying each concentration, 
the stoichiometry was not able to be determined yet.  If the CD data agrees with the 
stoichiometry of protein-dsRNA interaction from the sedimentation results, it would be a 
very strong evidence to support the Cole lab’s new overlapping lattice model.
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